Geneva Acquisition Corp.

Greg is currently a general partner of Nexus Medical Partners, a private equity firm specializing in healthcare investments. He has over 20 years of venture capital investment experience, having played a leadership role in the management of six venture capital funds. Greg has been a founder or early investor in many companies. He has been an active Board member of both public and private corporations, providing assistance and guidance on issues associated with business strategy, corporate expansion, organizational development, and becoming successful publicly traded companies. Prior to joining Nexus, Greg was a general partner of Prince Ventures, an independent, medically focused, venture capital partnership. His investments included PerSeptive Biosystems (bioseparations products) which was sold to Perkin Elmer for over $300 million. During the 1980s, Greg was Vice President and Special Limited Partner of the Vista Group where he worked closely with Ed Snape, the leader of Vista 's health care practice. He was a founding investor in numerous successful companies including Focus Healthcare, an HMO that was sold to Lincoln National Insurance Company for a substantial return. From 1972 until 1979, Greg was an executive with Baxter Laboratories. His three member team was responsible for bringing CAPD (Continuous Ambulatory Peritoneal Dialysis) into Baxter, where it became the second-most profitable product line in the company, then accounting for approximately 20% of Baxter's total profits. Greg received a BS in aerospace and mechanical engineering from Princeton University ; an MS in mechanical engineering the Massachusetts Institute of Technology (MIT); and an MS from MIT's Sloane School of Management. His hobbies include Dixieland clarinet/soprano sax, skiing and tennis. As a charity auctioneer, Greg has helped to raise several million dollars for local charities.